Warning! GuruFocus has detected 2 Severe warning signs with NNVC. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Also Trade In: Germany
Current and historical daily P/E ratio for NNVC (Nanoviricides Inc) from 2005 to May 07 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Nanoviricides stock (NNVC) PE ratio as of May 07 2021 is 0. More Details
Nanoviricides PE Ratio (TTM) Historical Data
View and export this data going back to 2005. Start your Free Trial
Nanoviricides PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
1 Controls Drive, Shelton, CT, USA, 06484
Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy.